Ardsley Advisory Partners’s Eli Lilly LLY Stock Holding History

Ardsley Advisory Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5,000	Closed	-$4.6M	–	182
2026 Q1	$4.6M	Sell	5,000 -35,000	-88%	-$35.5M	0.59%	54
2025 Q4	$43M	Buy	+40,000	New	+$38.2M	4.72%	1
2019 Q4	–	Sell	-4,000	Closed	-$447K	–	172
2019 Q3	$447K	Sell	4,000 -4,500	-53%	-$501K	0.1%	95
2019 Q2	$942K	Buy	8,500 +3,500	+70%	+$412K	0.15%	69
2019 Q1	$649K	Buy	+5,000	New	+$608K	0.12%	71
2018 Q1	–	Sell	-7,500	Closed	-$634K	–	158
2017 Q4	$634K	Buy	+7,500	New	+$638K	0.08%	88
2017 Q3	–	Sell	-2,500	Closed	-$206K	–	147
2017 Q2	$206K	Sell	2,500 -5,000	-67%	-$408K	0.03%	127
2017 Q1	$631K	Buy	7,500 +1,000	+15%	+$80.1K	0.1%	89
2016 Q4	$478K	Buy	+6,500	New	+$484K	0.08%	88
2014 Q1	–	Sell	-5,000	Closed	-$255K	–	256
2013 Q4	$255K	Buy	+5,000	New	+$250K	0.03%	131

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Ardsley Advisory Partners's LLY Position: Q2 2026 in Review

Ardsley Advisory Partners sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 5,000 shares — an estimated $4.6M sold.

Ardsley Advisory Partners first reported a position in LLY in Q4 2013 and held it in 10 quarters. The position peaked at $43M in Q4 2025. 1,692 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Ardsley Advisory Partners reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
Ardsley Advisory Partners sold 5,000 Eli Lilly shares in Q2 2026, an estimated $4.6M.
Ardsley Advisory Partners first reported a position in Eli Lilly in Q4 2013 and held it in 10 quarters.
Ardsley Advisory Partners's Eli Lilly position peaked at $43M in Q4 2025.
1,692 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Ardsley Advisory Partners's 13F filing for Q2 2026, filed 13 Jul 2026.